Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study gives fresh insight into canine hepatobiliary disease
Labrador retrievers were among the dog breeds found to be at increased risk of chronic hepatitis.

Work could increase a veterinary surgeon’s index of a particular liver condition.

New research led by researchers at Queen's Veterinary School Hospital, the University of Cambridge, has revealed fresh insights into canine hepatobiliary disease.

The study published in the Journal of Small Animal Practice (JSAP) is the first of its kind to document the histopathological frequency of hepatobiliary disease in a large group of dogs in the United Kingdom.

The team hopes that the work may help increase a veterinary surgeon’s index of particular liver disease, particularly if a diagnosis cannot be obtained through biopsy.

In the study, researchers reviewed histopathology reports from canine liver tissues submitted to a commercial laboratory by first and second opinion veterinary practices. Data gathered included breed, age, sex, gross and histological descriptions, diagnosis and additional comments. 
 
The scientists grouped the data into 23 categories according to WSAVA histological criteria for canine hepatobiliary diseases. A breed analysis was also performed on the top five ranking breeds within each category. 

Of the 4,584 reports included in the analysis, the most common histopathological diagnoses were reactive hepatitis, chronic hepatitis and reversible hepatocellular injury. Labrador retrievers were found to have increased odds for reactive hepatitis, while crossbreeds demonstrated reduced odds.

The team also found that breeds with increased risk of chronic hepatitis included the Labrador retriever, springer spaniel, cocker spaniel, and West Highland White Terrier. Within the RHI group, the schnauzer and Bichon Frise had increased odds of disease. 

“This is the first study to report the histopathological frequency of hepatobiliary diseases and to identify possible breed predispositions in a large cohort of dogs in the UK,” commented Dr Yuvani Bandara, corresponding author for the paper.

“Despite multivariable analysis not being performed to account for confounding factors, we hope that this information informs and supports future investigations for hepatic disease in particular breeds and potential predisposition.”

Nicola Di Girolamo, Editor of JSAP, added: “By increasing knowledge of the varying histopathological frequencies of different canine hepatobiliary diseases in the UK and by providing data on breed predispositions, this study may help assist in increasing a veterinary surgeon’s index of suspicion of a particular liver disease. This may be particularly important in cases where a biopsy-confirmed diagnosis cannot be obtained.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.